ExoLabz logo
support@exolabz.ca
Co-elution: When One Peak Is Two Compounds

Co-elution: When One Peak Is Two Compounds

A chromatogram shows peaks, and the arithmetic behind a purity figure assumes each peak is one compound. That assumption fails more often than the figure suggests. When two species leave the column at the same time, the detector records a single peak, and everything under it is counted as the target.

Why it happens

Separation on a reversed-phase column depends on differences in hydrophobicity. Two molecules with similar hydrophobicity travel at similar speeds, and if the difference is small enough relative to peak width, they arrive together.

The impurities most likely to do this are the ones closest in structure to the target, which is exactly the population a purity test exists to find. A single-residue deletion sequence, a deamidated species, or a diastereomer produced by racemisation during synthesis can all sit within a whisker of the parent on retention time. Deletion, truncation and oxidation impurities covers what each of those is.

What it does to the number

It inflates it, always in the supplier’s favour. If a co-eluting impurity contributes 3% of the area and is counted inside the main peak, a genuinely 95% pure material reports as 98%. Nothing on the chromatogram looks wrong; there is simply one peak where there should have been two.

This is why a purity figure quoted without the chromatogram is a weaker claim than it appears. A number cannot be inspected for shoulders; a trace can.

How it is detected

  • Peak shape. Co-elution frequently produces a shoulder, a broadened base, or an asymmetry the method does not otherwise explain. It is the cheapest signal and the easiest to overlook.
  • Peak purity by diode array. A photodiode array detector records a full spectrum across the peak rather than absorbance at one wavelength. If the spectrum at the leading edge differs from the spectrum at the trailing edge, more than one species is present. This is the standard test and it is decisive when the two species have different chromophores.
  • Orthogonal separation. Run the same sample by a method that separates on a different principle — a different column chemistry, a different pH, or ion-exchange rather than reversed-phase. Species that co-elute under one mechanism rarely co-elute under another.
  • Mass spectrometry across the peak. An LC-MS run reports the mass of what is eluting moment by moment. Two masses under one peak is unambiguous.

Diode-array peak purity has a blind spot worth knowing: it cannot distinguish species with identical spectra. A diastereomer, or an isoaspartate rearrangement, absorbs exactly like the parent. For those, orthogonal separation or mass spectrometry is the only route.

What to ask for

The chromatogram rather than the percentage, the detection wavelength, and whether peak purity was assessed. A laboratory running a validated method will have considered co-elution during method development, which is part of what system suitability and resolution criteria exist to control.

Where the same vial has been analysed twice with different answers, co-elution under one method and not the other is a common explanation. Why certificates of analysis disagree covers the full set.

What it does not tell you

Detecting co-elution establishes that more than one species is present under a peak. It does not identify the second species, quantify it, or say when it formed. And as with every identity and purity measurement, it addresses composition only — not sterility, not endotoxin, and not suitability for use in a person or an animal. Endotoxin, sterility and the limits of research grade covers that boundary.

All material is supplied for laboratory research use only. It is not a drug, not a supplement, and not for use in humans or animals.

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*

Legal Disclaimer

The products offered by ExoLabz are intended solely for research purposes. These products are not for human consumption, are not intended for medical use, and have not been approved by the FDA or Health Canada for any therapeutic or diagnostic purpose. ExoLabz makes no claims regarding the safety, efficacy, or intended use of these products outside of a controlled research environment. By purchasing our products, you agree to use them strictly for scientific research and in compliance with all local laws and regulations.

GLP-1 15mg research peptide vial - ExoLabz Canada
0
    0
    Your Cart
    Your cart is empty